Current Research: Pediatric Hematology-Oncology


Brain


Project

Sponsor

Begin Date

End Date

AGCT0132 – Phase III Study of Reduced Therapy in the Treatment of Children with Low and Intermediaate Risk Extracranial Germ Cell Tumors

Children’s Oncology Group (COG) Sept 2005 Oct 2010

ACNS0221-- A Phase II Study of Conformal Radiotherapy in Patients with Low-Grade Gliomas

 Children’s Oncology Group (COG) Mar 2006 Mar 2010

ACNS02B3 -- A Children’s Oncology Group Protocol for Collecting & Banking Pediatric Brain Tumor Research Specimens

Children’s Oncology Group (COG)

 Apr 2004 Ongoing
ACNS0331 --  A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy 18.00 Gy and Chemotherapy In Children with Newly Diagnosed Standard Risk Medulloblastoma Children’s Oncology Group (COG) Nov 2004 Dec 2009

ANBL00P2 --  Pilot Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

Children’s Oncology Group (COG)

 Jan 2005 Jan 2010
ANBL00B1 --  Phase III Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplantation After Dose-Intensive Induction Chemotherapy in Patients With Newly Diagnosed High Risk Neuroblastoma or Ganglioneuroblastoma Children’s Oncology Group (COG) Sept 2004 Sept 2014
ANBL0531 --  Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma Children’s Oncology Group (COG) Feb 2008 Sept 2012

Genitourinary

Project

Sponsor

Begin Date

End Date
AREN03B2 -- Renal Tumors Classification, Biology, and Banking Study Children’s Oncology Group (COG); National Cancer Institute (NCI) Mar 2007 Ongoing

AREN0532-- Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor

 Children’s Oncology Group (COG); National Cancer Institute (NCI) Mar 2007 Feb 2011

CCG4941L --National Wilms Tumor Late Effects Study

Emory University

 Jun 2005 Ongoing

Hematological Malignancy

Project

Sponsor

Begin Date

End Date
AALL03B1-- Classification of Acute Lymphoblastic Leukemia Children’s Oncology Group (COG); National Cancer Institute (NCI); Emory University Feb 2005 Feb 2011

AALL0232 -- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

 Cancer and Leukemia Group B (CALGB); National Cancer Institute (NCI); Eastern Cooperative Oncology Group (ECOG); Southwest Oncology Group (SWOG) May 2005 Sept 2012

AALL0331 -- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Children’s Oncology Group (COG); National Cancer Institute (NCI)

 Jul 2005 Sept 2009
AALL0433 -- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Children’s Oncology Group (COG); National Cancer Institute (NCI) Oct 2007 Feb 2012
AALL0434 -- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia Children’s Oncology Group (COG); National Cancer Institute (NCI) Aug 2007 Jan 2013
AALL03N1-- Understanding the Role of Adherence in the Ethnic Differences in Survival After Childhood ALL Children’s Oncology Group (COG); National Cancer Institute (NCI) Jul 2005 May 2010
AAML0531 -- A Phase III Randomized Trial of Gemtuzumab Ozogamicin Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia in Children, Adolescents, and Young Adults Children’s Oncology Group (COG); National Cancer Institute (NCI) May 2007 Aug 2010
AHOD0031 -- Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease Children’s Oncology Group (COG); National Cancer Institute (NCI) Mar 2005 Jun 2010

Solid Tumors

Project

Sponsor

Begin Date

End Date
AOST0331-- A randomized trial of the European and American Osteosarcoma Study Group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy. Children’s Oncology Group (COG); National Cancer Institute (NCI); University College London Hospitals Sept 2007 Jun 2010

ARST0321-- Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

 Children’s Oncology Group (COG); National Cancer Institute (NCI) Sept 2005 Oct 2009

ARST0331 -- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

 Children’s Oncology Group (COG); National Cancer Institute (NCI) Oct 2004 Aug 2010

Misc Sample Banking Trials

Project

Sponsor

Begin Date

End Date
ABTR06C1 -- Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer Children’s Oncology Group (COG); National Cancer Institute (NCI) Aug 2007 Ongoing

ACCRN07 -- Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

 Children’s Oncology Group (COG) Feb 2008 Ongoing
ALTE03N1 --Study of Late-Occurring Complications in Childhood Cancer Survivors Children’s Oncology Group (COG); National Cancer Institute (NCI) Nov 2007 Ongoing

COG-D9902 --Study to Collect and Characterize Tissue Specimens From Patients With Rhabdomyosarcoma Or Non-Rhabdomyosarcoma Soft Tissue Sarcoma

Children’s Oncology Group (COG) Oct 2004 Ongoing
Revised March 30, 2009.   Please send comments, suggestions or questions about this page to Goldei Posey, gposey@mcg.edu .